Endoscopic submucosal dissection (ESD) enables en bloc resection for early gastrointestinal malignancies but is technically ...
"In Italy, every 25 minutes we have a death from colorectal cancer, one of the 'big killers' in oncology if not diagnosed in ...
Boston Scientific (BSX) stock rises as the company beats Q3 forecasts and raises full-year outlook thanks to strong ...
Vesey Street Capital Partners (VSCP) completed the full exit of portfolio company, Gastro MD, to AGA, LLC, an affiliate of United Digestive. Under our ownership the company achieved significant growth ...
Achalasia is an uncommon but debilitating disorder, with an estimated incidence of 1.63–4.0 per 100,000 people. Diagnosis relies on high-resolution ...
Attracted by a Chinese-developed spinal endoscopic technology known as uni-port bi-channel dual-media, or UBD, which reduces ...
HealthDay on MSN
Recommendations Issued for Surveillance of Barrett Esophagus
Recommendations have been developed for surveillance of Barrett esophagus (BE), according to a report published in the ...
TipRanks on MSN
Creo Medical Announces Capital Markets Day for Investors
The latest announcement is out from Creo Medical ( (GB:CREO) ).
Vietnam Investment Review on MSN
PENTAX Medical 2025: C2 CryoBalloon Line Sold to Merit Medical
The asset transfer signals a strategic pivot toward endoscopic imaging rather than ablative therapy, reflecting broader ...
The full details of Wycombe Hospital’s long-awaited redevelopment have now been unveiled following the submission of a planning application.
7don MSN
Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum
Discover Boston Scientific's Q3 2025 earnings: double-digit revenue growth, raised guidance, and innovation in cardiovascular and MedSurg.
MONTVALE, N.J., Oct. 16, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results